ArticleJournal of thrombosis and haemostasis : JTH2022

Commentary on "Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa": Small molecule factor XIa inhibitor asundexian allows for safer anticoagulation.

Reiner K Mailer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.